Drug Type Oligonucleotide |
Synonyms HC016脂质复合物, HC016 |
Target |
Mechanism TLR9 agonists(Toll like receptor 9 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | IND Approval | US | 18 Jan 2025 | |
Melanoma | IND Approval | US | 18 Jan 2025 | |
Osteosarcoma | IND Approval | US | 18 Jan 2025 |